Koi Peptides Canada
koipeptidescanada.com
Email me when this record changes
Following this record emails you when it gains a dated entry or its published claims are re-read, and nothing about any other supplier. No topic below is ticked: tick one only if you also want it in the same email.
1 recorded documentation gap also on file, subtracted from the score.
Compiled automatically from the dated observations in this vendor's record. How we evaluate.
Never merged into one number. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.
Koi Peptides Canada's COA library lists a retatrutide certificate at lot KOI-2026-0422-B, 99.1 percent purity, tested April 22, 2026, but the actual PDF behind that listing, downloaded and read directly along with its BPC-157 and Tirzepatide neighbors and the retatrutide endotoxin companion, names the client of record as Blank Peptides, not Koi, all four sharing one April 6, 2026 receipt date and one sequential accession run at the issuing lab, Freedom Diagnostics. That same lab's public index separately holds a later, correctly attributed June 2026 batch of Koi-specific certificates, including a retatrutide document at 99.51 percent purity by HPLC-UV, that the vendor does not publish anywhere on its own site. The mailing address in the site footer and on the Contact page reads, verbatim, "100 Placeholder Drive, Unit 200, Mississauga, ON L5N 0A1", under the registered name Koi Research Labs Canada Inc., while the Terms of Service instead names the contracting party Koi Peptides LLC, twice. Has anyone who ordered from this vendor received a certificate matching the June 2026 batch the lab actually holds on file, rather than the April document the site's own COA page shows?
What the record holds
NO FIRM COMMITMENT
“domestic Canadian standard service costs $14.95 CAD, free over $200 CAD, 1 to 4 business days via Canada Post Xpresspost”
Shipping policy page carrying an April 2026 revision dateline. The 1 to 4 business day figure is a delivery estimate via the named carrier, not a dispatch or processing commitment, so the weaker class applies. Purolator Express and Express 9 AM at carrier cost; cold-chain shipments dispatch Monday or Tuesday only; international offered only to qualifying institutions gated on an institutional address, an end-use declaration, and pre-approval.
Read from this supplier's own pages on 2026-08-26. This publication has never placed an order with any supplier. This row records what is written and measures nothing about what actually happens after an order.
Compound retatrutide 10mg
Listed as Retatrutide 10mg -30mg, 10 mg size variant, SKU RETATRUTIDE-10-MG, on the product page titled Buy Retatrutide In Canada
Price as recorded Priced in Canadian dollars, not United States dollars. The ten milligram single vial reads one hundred even; the thirty milligram single vial reads two hundred eighty; both CAD, taken from the product page's own WooCommerce variation payload rather than the displayed price-range widget.
Read on 2026-08-26. One reading on one day, and prices are not tracked over time here.
This supplier was not part of the Trustpilot reading of 2026-08-25, which covered 59 of the 126 suppliers on file. That is a fact about this publication's coverage, stated rather than left to be read either way.
3 claims from this publication's own dossier on this supplier were read again against the live site on 2026-08-26: 1 held, 2 corrected before publication.
A corrected claim is an error of ours that the re-read caught before it reached a page. This line tracks this publication's own accuracy. It says nothing about the supplier.
Dated entries
4 observations on file, recorded 2026-08-26. Newest first, appended and never rewritten.
Certificates are published from a COA library at /coa/, fetched today, listing 32 documents indexed by compound, lot ID in a KOI-2026-MMDD-X format, purity, and test date, alongside a companion endotoxin document for most compounds. The retatrutide row reads lot KOI-2026-0422-B, purity 99.1 percent, tested April 22 2026, with a linked PDF. I downloaded that PDF and the ones behind the BPC-157 and Tirzepatide rows and read their text layers directly rather than opening them in a browser. All three, plus the retatrutide endotoxin companion, are the same template from the same issuer, Freedom Diagnostics Testing, and all four list the client of record as Blank Peptides rather than Koi: retatrutide carries accession 2604060210, search code Blan2604060210, received 04/06/2026, reported 04/7/2026, lot printed on the document as Reta 10mg 665394, net peptide content 10.01 mg, purity 99.887 percent by HPLC with UV detection coupled to mass spectrometry, identity reading GLP RT, signed by a chemist named Alex Johnson. BPC-157 carries accession 2604060200, same received and reported dates, lot BPC-157 10mg 665394, net content 11.25 mg, purity 99.283 percent by the same method. Tirzepatide carries accession 2604060212, same dates, lot Tirz 10mg 665394, net content 11.64 mg, purity 99.714 percent. The retatrutide endotoxin companion, accession 2604060211, reports only two duplicate Pass findings against a USP <85> guideline reference, with no numerical EU/mg figure on the document. The catalogue itself, read from the site navigation and the COA library's compound list, covers fifteen distinct items: AOD-9604, BPC-157, BPC-157 plus TB-500 (labelled Wolverine on the COA table), CJC-1295 no DAC plus Ipamorelin, GHK-Cu, GLOW, Ipamorelin, KLOW, MOTS-C, NAD+, Retatrutide, Semaglutide, Sermorelin, TB-500, and Tesamorelin, plus Tirzepatide, all sold as single vials with size variants rather than as multi-vial kits.
On lab verifiability, exercised directly rather than described. freedomdiagnosticstesting.com resolves to a live laboratory site today, giving a Franklin, Tennessee address, an establishment year of 2023, a two to four day turnaround claim, and a count of roughly 42,000 published certificates; the words accreditation, ISO 17025, A2LA, and CLIA appear nowhere on that homepage. Querying the lab's public accession index for the company name Blank Peptides returned 26 search codes, Blan2604060200 through Blan2604060227 with a few numbers skipped, the identical accession run behind the retatrutide, BPC-157, and Tirzepatide documents Koi Peptides Canada publishes on its own live COA page today. A separate query for Koi Peptides returned a different and later set, 14 search codes dated June 2026 (KOIp2606080810 through KOIp2606080826, plus KoiP2606170094 and KoiP2606170096), none of which appear anywhere on koipeptidescanada.com's COA library. I pulled and read several: a genuine 10 mg retatrutide document, accession 2606080823, client KOI peptides, lot 612026R10, received 06/08/2026, reported 06/10/2026, purity 99.51 percent by HPLC-UV with identity confirmed by LC-MS, net content 9.87 mg against the 10 mg label; a 20 mg retatrutide document, accession 2606170094, lot Clear Cap/Bronze Crimp, purity 99.76 percent, net content 21.01 mg; and documents for NAD+ 1000mg (99.94 percent), Tirzepatide 15mg and 30mg, GHK-Cu 50mg, Semax, Selank, KPV, Epithalon, MOT-C 40mg, and Ipamorelin, all under the same client attribution and all newer than what the vendor's own COA page shows. So the laboratory that Koi's site describes only as an unnamed independent laboratory does hold correctly attributed, more recent Koi-specific documents; the vendor is not the one publishing them.
Benchmark and prices read on 2026-08-26 from the product page and its embedded WooCommerce variation data. Retatrutide is listed on a single product titled Retatrutide 10mg -30mg, with a page title separately advertising a purity of 99.69 percent with no method named at that claim site. Two single-vial size variants: 10 mg, SKU RETATRUTIDE-10-MG, priced in Canadian dollars at one hundred even, and 30 mg, SKU RETATRUTIDE-30-MG, priced at two hundred eighty, both CAD, confirmed against the page's own data-product_variations payload. Also recorded, all CAD, all single vials: Tirzepatide 30mg-10mg range 157.52 to 217.80, GHK-Cu range 45.00 to 94.51. Payment methods differ by page: the product page's own FAQ schema states Visa, Mastercard, Interac e-Transfer, and Bitcoin, with approved institutional buyers able to place net-30 orders against a purchase order, while the Terms of Service instead lists major credit cards, Interac e-Transfer, and wire transfer, naming no Bitcoin option; checkout itself was not reached, so what is actually offered there is unverified. Shipping: domestic Canadian standard service costs $14.95 CAD, free over $200 CAD, 1 to 4 business days via Canada Post Xpresspost, with Purolator Express and Purolator Express 9 AM available at carrier cost; the shipping policy page carries an April 2026 revision date on its face. International shipping is offered to qualifying institutions in the United States, the UK, the EU, Australia, and select APAC countries, gated on an institutional address, an end-use declaration, and pre-approval, with customs and duties on the recipient; cold-chain shipments dispatch Monday or Tuesday only. Entity and contact: the mailing address printed on the Contact page and repeated in the sitewide footer reads, verbatim on the page, 100 Placeholder Drive, Unit 200, Mississauga, ON L5N 0A1, Canada, under the registered name Koi Research Labs Canada Inc.; the phone number given is 709-866-7507, a Newfoundland area code despite the Ontario address. The Terms of Service page instead names the contracting party as Koi Peptides LLC twice, a different legal name from the one on the Contact page and the sitewide footer, both live on the site today. The tie to koipeptides.com, a separate storefront under the same Koi branding documented in the kylopeptides.com record below, is not a clickable header link: every logo anchor on the pages fetched points back to koipeptidescanada.com itself, and the connection sits instead in reciprocal hreflang alternate tags in the page head naming koipeptides.com as this store's United States edition, plus the entry-gate modal's Koi logo image, which is served directly from koipeptides.com's own uploads directory.
CAUTIONCautions noted. First, an accreditation claim asserted outright across the homepage, the product page, the About page, the FAQ, and the COA page, all describing an unnamed independent ISO/IEC 17025-accredited laboratory, while the quality-standards page, the site's most detailed page on testing methodology, notably stops short of that claim, citing 17025 only as what independent labs in this space typically work under and as a due-diligence question a reader should put to any supplier; a text search across the About, quality-standards, methodology, lab-services, FAQ, and COA pages for the actual laboratory name returns nothing (methodology and lab-services carry no accreditation language at all), and the identity is discoverable only by opening a certificate PDF, which names Freedom Diagnostics Testing, a lab that carries no accreditation language on its own site today. Second, every certificate I actually opened from the live COA page today, covering retatrutide, BPC-157, Tirzepatide, and the retatrutide endotoxin companion, lists the client of record as Blank Peptides, sharing one April 6 2026 receipt date and a single sequential accession run, directly against the About page's own claim that the COA on the product page is the COA for the batch in the vial and that nothing is recycled across batches. Third, the lab's own public index holds a separate, later, and correctly attributed June 2026 batch of Koi-specific documents that the vendor does not publish anywhere, as detailed in the lab-verifiability note above. Fourth, the FAQ describes two testing passes, an internal HPLC and LC-MS check plus a blind outside retest, with both sets of findings published on the lot page; the live COA table shows only one purity figure and one outside-lab document per lot, with no second internally generated data set visible anywhere. Fifth, reconstituted storage guidance conflicts between two FAQ sections of the same site: the About page's embedded FAQ block states that after reconstitution the vial should be stored at 2 to 8 degrees C, while the standalone FAQ page states that reconstituted aliquots should be stored at minus 80 degrees C, a substantial disagreement on the same instruction. Sixth, the entity and address anomalies recorded above, the literal Placeholder street address and the Koi Research Labs Canada Inc. versus Koi Peptides LLC naming conflict. Seventh, on the wider family and a correction to the working hypothesis behind this assignment: koiaminos.com, fetched today, shows no evidence of being the same operation as koipeptidescanada.com. It is a separate WordPress and React buyer's-guide site with its own name, its own entity-free branding, and no structured-data tie to Koi Peptides Canada or Koi Research Labs anywhere I found; what it actually does is rank kylopeptides.com first among Retatrutide suppliers and link to it with tracked referral parameters, a relationship documented in full in the kylopeptides.com record below. The evidenced sibling relationship instead runs from koipeptidescanada.com to koipeptides.com, tied not by any clickable link but by reciprocal hreflang alternate tags in each site's own page head and by the Canadian site hot-linking its entry-gate logo image straight from koipeptides.com's uploads directory, so no shopper following on-page links would ever surface the connection; koipeptides.com is a US-facing storefront whose own structured data names its legal entity Koi Research Labs LLC at a Sheridan, Wyoming street address that is the identical address, suite letter included, printed by Kylo Labs LLC, the operator of kylopeptides.com; that address match, and its significance, is documented fully in the kylopeptides.com record rather than repeated here, since koipeptidescanada.com itself carries no direct reference to Kylo, Kylo Labs, or kylopeptides.com anywhere I loaded. This entire finding set, and the koiaminos.com correction specifically, is flagged for Fable's attention.
Reader reviews
No reader review of this supplier is published yet. Every review is read and checked against the record before it appears. Add a review.
Open this supplier
Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.